NEU

3.50%

$14.05 neuren pharmaceuticals limited

Share Price, page-583

First 583 Last

Share
Profile

Follow
zedcorp

2,211 Posts.

326

26/12/21

15:43

Post #: 58521926
Share

Originally posted by Little T ↑

I had another look at my initial post on the 19th of October 2021 and after speaking to Jon Pilcher and rewatching the successful trofinetide results update on the zoom webinar I make the following comments .
1. Current capitalisation of the company is approx $468 million .Compared with other biotech companies they are still very undervalued .I believe most of the selling in the stock has been finished ,from my experience the selling washout normally takes about 10 trading days to complete .
2. Based on the recent share register I obtained insto buying have been coming from 2 nz funds and the selling mainly from retail.
3. Buying from other overseas buying has been limited ,I expect that to pick up early in the new year when Jon Pilcher has the oppportunity to talk to the many overseas instos and funds he has previously spoken to .
4. Jon Pilcher mentioned that the results were better than he had hoped for .
5.Jon is still very confident on the prospects on NNZ2591 especially more so after recent trofinetide results .
6. The company would still have about $32 mill in the bank .
7. More analysts will have Neuren on their radar going forward .Currently valuations are between low $5 and high $7’s.
8. Acadia has become more of a takeover target now their pipeline has been expanded with trofinetide ,there is a lot of money looking for investments in the biotech/pharma space .
9. Neuren at current levels is definitely a takeover target as someone could buy Neuren and potentially get access to royalties/milestones of over $800 million, ROW and NNZ2591 including 4 indications with possibly a lot more in the autism space ,cash in the bank and tax losses .
10. I have been in the stock for just on nine years and am very confident that the company has never been in a better position than now !!!!

Expand

Have you increased your previous T/O valuation of $8?
Way too low in my mind.

Last edited by zedcorp: 26/12/21

NEU Price at posting: $3.63 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 11,581 more messages in this thread...

First 583 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.05		Change -0.510(3.50%)		Mkt cap ! $1.795B

Open	High	Low	Value	Volume
$14.38	$14.42	$13.94	$6.419M	454.6K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$13.99

Sellers (Offers)

Price($)	Vol.	No.
$14.07	6644	4

View Market Depth

No.	Vol.	Price($)
1	500	13.990
1	300	13.970
1	1432	13.950
2	1230	13.900
1	720	13.890

Price($)	Vol.	No.
14.420	175	1
14.500	2985	2
14.800	2850	2
14.860	500	1
14.960	445	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

NEU (ASX) Chart

Share Price, page-583

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Share Price, page-583

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News